Pitavastatin(Phenylethylamine Salt) NEW

Product Number: P001000A
English Name: Pitavastatin(Phenylethylamine Salt)
English Alias: (R)-1-phenylethanamine (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate
CAS Number: 147511-70-4
Molecular Formula: C25H24FNO4.C8H11N 
Molecular Weight: Approximately 542.64 

Pitavastatin is a statin drug commonly used to lower cholesterol levels in the blood to prevent and treat cardiovascular diseases. Its mechanism of action is mainly to inhibit hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase and reduce the biosynthesis of cholesterol. Pitavastatin (Phenylethylamine Salt), as a salt form of Pitavastatin, is of great significance in pharmaceutical preparations. The choice of salt form can affect key properties of the drug such as solubility, stability, and bioavailability.

In terms of the current research status, the research on Pitavastatin (Phenylethylamine Salt) involves multiple fields. In the field of medicinal chemistry, researchers are committed to developing more efficient and safer synthetic routes to improve the yield and purity of this compound while reducing production costs. By improving reaction conditions, optimizing catalysts and reaction solvents, etc., they are constantly exploring greener synthetic methods. In the field of pharmacology research, further exploration of the mechanism of action of Pitavastatin (Phenylethylamine Salt) in the body, including its regulation of the expression of genes related to cholesterol metabolism and its interactions with other drugs, to gain a more comprehensive understanding of its efficacy and safety. In the field of pharmaceutical preparations, research on how to improve the dissolution characteristics and bioavailability of the drug through appropriate dosage form design, such as tablets and capsules, to improve patients' medication compliance. In addition, in clinical research, evaluating its efficacy and safety in different populations and exploring new clinical application areas, such as its therapeutic effect in specific subgroups of cardiovascular diseases.